Intellectual Property India Publishes Patent Application for 'Compositions And Methods For Treatment Of Huntington's Disease' Filed by Atalanta Therapeutics, Inc.

MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517027648 A) filed by Atalanta Therapeutics, Inc., Boston, on March 25, for 'compositions and methods for treatment of huntington's disease.'

Inventor(s) include Hassler, Matthew; Curtis, Daniel; Da Cruz Godinho, Bruno, Miguel; and Kinberger, Garth, A.

The application for the patent was published on April 18, under issue no. 16/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides single- or double-stranded interfering RNA molecules (e.g., siRNA) that target a Huntingtin (HTT) gene. The interfering RNA molecules may contain specific patterns of nucleoside modifications and internucleoside l...